Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures

Autoimmune liver diseases (AILD) often lead to transformation of the liver tissues into hepatocellular carcinoma (HCC). Considering the drawbacks of surgical procedures in such cases, need of successful non-invasive therapeutic strategies and treatment modalities for AILD-associated-HCC still exists...

Full description

Bibliographic Details
Main Authors: Soumyadeep Mukherjee, Arpita Kar, Najma Khatun, Puja Datta, Avik Biswas, Subhasis Barik
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/8/1917
_version_ 1797524283455438848
author Soumyadeep Mukherjee
Arpita Kar
Najma Khatun
Puja Datta
Avik Biswas
Subhasis Barik
author_facet Soumyadeep Mukherjee
Arpita Kar
Najma Khatun
Puja Datta
Avik Biswas
Subhasis Barik
author_sort Soumyadeep Mukherjee
collection DOAJ
description Autoimmune liver diseases (AILD) often lead to transformation of the liver tissues into hepatocellular carcinoma (HCC). Considering the drawbacks of surgical procedures in such cases, need of successful non-invasive therapeutic strategies and treatment modalities for AILD-associated-HCC still exists. Due to the lack of clear, sufficient knowledge about factors mediating AILD-to-HCC transition, an in silico approach was adopted to delineate the underlying molecular deterministic factors. Parallel enrichment analyses on two different public microarray datasets (GSE159676 and GSE62232) pinpointed the core transcriptional regulators as key players. Correlation between the expression kinetics of these transcriptional modules in AILD and HCC was found to be positive primarily with the advancement of hepatic fibrosis. Most of the regulatory interactions were operative during early (F0–F1) and intermediate fibrotic stages (F2–F3), while the extent of activity in the regulatory network considerably diminished at late stage of fibrosis/cirrhosis (F4). Additionally, most of the transcriptional targets with higher degrees of connectivity in the regulatory network (namely DCAF11, PKM2, DGAT2 and BCAT1) may be considered as potential candidates for biomarkers or clinical targets compared to their low-connectivity counterparts. In summary, this study uncovers new possibilities in the designing of novel prognostic and therapeutic regimen for autoimmunity-associated malignancy of liver in a disease progression-dependent fashion.
first_indexed 2024-03-10T08:55:08Z
format Article
id doaj.art-07d9ec14b9904069875d7daffc7c1b88
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T08:55:08Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-07d9ec14b9904069875d7daffc7c1b882023-11-22T07:09:10ZengMDPI AGCells2073-44092021-07-01108191710.3390/cells10081917Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional SignaturesSoumyadeep Mukherjee0Arpita Kar1Najma Khatun2Puja Datta3Avik Biswas4Subhasis Barik5Department of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, Kolkata 700026, IndiaDepartment of Signal Transduction and Biogenic Amines, Chittaranjan National Cancer Institute, Kolkata 700026, IndiaDepartment of Signal Transduction and Biogenic Amines, Chittaranjan National Cancer Institute, Kolkata 700026, IndiaDepartment of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, Kolkata 700026, IndiaDepartment of Signal Transduction and Biogenic Amines, Chittaranjan National Cancer Institute, Kolkata 700026, IndiaDepartment of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, Kolkata 700026, IndiaAutoimmune liver diseases (AILD) often lead to transformation of the liver tissues into hepatocellular carcinoma (HCC). Considering the drawbacks of surgical procedures in such cases, need of successful non-invasive therapeutic strategies and treatment modalities for AILD-associated-HCC still exists. Due to the lack of clear, sufficient knowledge about factors mediating AILD-to-HCC transition, an in silico approach was adopted to delineate the underlying molecular deterministic factors. Parallel enrichment analyses on two different public microarray datasets (GSE159676 and GSE62232) pinpointed the core transcriptional regulators as key players. Correlation between the expression kinetics of these transcriptional modules in AILD and HCC was found to be positive primarily with the advancement of hepatic fibrosis. Most of the regulatory interactions were operative during early (F0–F1) and intermediate fibrotic stages (F2–F3), while the extent of activity in the regulatory network considerably diminished at late stage of fibrosis/cirrhosis (F4). Additionally, most of the transcriptional targets with higher degrees of connectivity in the regulatory network (namely DCAF11, PKM2, DGAT2 and BCAT1) may be considered as potential candidates for biomarkers or clinical targets compared to their low-connectivity counterparts. In summary, this study uncovers new possibilities in the designing of novel prognostic and therapeutic regimen for autoimmunity-associated malignancy of liver in a disease progression-dependent fashion.https://www.mdpi.com/2073-4409/10/8/1917autoimmune liver diseasehepatocellular carcinomaHCC transcriptomicshepatic fibrosisliver cirrhosisgene regulatory network
spellingShingle Soumyadeep Mukherjee
Arpita Kar
Najma Khatun
Puja Datta
Avik Biswas
Subhasis Barik
Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures
Cells
autoimmune liver disease
hepatocellular carcinoma
HCC transcriptomics
hepatic fibrosis
liver cirrhosis
gene regulatory network
title Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures
title_full Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures
title_fullStr Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures
title_full_unstemmed Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures
title_short Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures
title_sort familiarity breeds strategy in silico untangling of the molecular complexity on course of autoimmune liver disease to hepatocellular carcinoma transition predicts novel transcriptional signatures
topic autoimmune liver disease
hepatocellular carcinoma
HCC transcriptomics
hepatic fibrosis
liver cirrhosis
gene regulatory network
url https://www.mdpi.com/2073-4409/10/8/1917
work_keys_str_mv AT soumyadeepmukherjee familiaritybreedsstrategyinsilicountanglingofthemolecularcomplexityoncourseofautoimmuneliverdiseasetohepatocellularcarcinomatransitionpredictsnoveltranscriptionalsignatures
AT arpitakar familiaritybreedsstrategyinsilicountanglingofthemolecularcomplexityoncourseofautoimmuneliverdiseasetohepatocellularcarcinomatransitionpredictsnoveltranscriptionalsignatures
AT najmakhatun familiaritybreedsstrategyinsilicountanglingofthemolecularcomplexityoncourseofautoimmuneliverdiseasetohepatocellularcarcinomatransitionpredictsnoveltranscriptionalsignatures
AT pujadatta familiaritybreedsstrategyinsilicountanglingofthemolecularcomplexityoncourseofautoimmuneliverdiseasetohepatocellularcarcinomatransitionpredictsnoveltranscriptionalsignatures
AT avikbiswas familiaritybreedsstrategyinsilicountanglingofthemolecularcomplexityoncourseofautoimmuneliverdiseasetohepatocellularcarcinomatransitionpredictsnoveltranscriptionalsignatures
AT subhasisbarik familiaritybreedsstrategyinsilicountanglingofthemolecularcomplexityoncourseofautoimmuneliverdiseasetohepatocellularcarcinomatransitionpredictsnoveltranscriptionalsignatures